Restructuring Phase Endo emerged from Chapter 11 as a private entity undergoing strategic realignment and asset divestitures. This creates opportunities for financial systems modernization, procurement optimization, and contract management services to support a lean operating model.

Simulation Platform The launch of a Spatial Computing Injection Simulator signals openness to digital health tools and training platforms. Potential to provide integration, data analytics, and customization services for pharmaceutical injection training and patient safety programs.

Marketing Push Active consumer marketing for Xiaflex indicates willingness to invest in brand-building and patient education. Potential to offer performance marketing, market research, and compliant creative services to support demand generation.

Manufacturing Support Portfolio includes generics launches, suggesting demand for contract manufacturing, packaging, regulatory support, and supply chain optimization for small-molecule products.

Capital & Partnerships Recent financing activity and asset transactions point to ongoing strategic moves; opportunities exist for capital markets advisory, licensing, co-development partnerships, or strategic investments to accelerate growth.